Table 14. Results of subgroup analysis by current treatment.
| Theme | Currently getting treatment? | ||
|---|---|---|---|
| Prevalence (%) | P value | ||
| Yes | No | ||
| Fatigue | 90.1 | 73.0 | 0.026* |
| Social role dissatisfaction | 53.1 | 25.0 | 0.0057* |
| Breathing difficulties | 65.0 | 70.3 | 0.68 |
| Impaired body image | 65.0 | 27.0 | <0.0001* |
| Impaired sleep and daytime sleepiness | 75.8 | 67.6 | 0.38 |
| Difficulty thinking | 65.7 | 54.1 | 0.24 |
| Limitations with physical function | 73.7 | 70.3 | 0.67 |
| GI issues | 63.3 | 48.7 | 0.17 |
| Social role limitations | 50.5 | 26.3 | 0.012* |
| Emotional issues | 79.8 | 55.3 | 0.0053* |
| Pain | 51.0 | 50.0 | 1.0 |
| Inability to do activities | 62.0 | 60.5 | 1.0 |
| Communication difficulties | 26.5 | 29.7 | 0.83 |
| Choking or swallowing issues | 27.6 | 31.6 | 0.68 |
Prevalence (%) and P values of symptomatic themes evaluated in cross-sectional study subgroup analysis by current treatment. *, P<0.05, statistical significance by the Benjamini-Hochberg method. GI, gastrointestinal.